[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"company:IDXX":3,"prompts:company:0000874716":22,"events:cik:0000874716":49},{"status":4,"company":5,"choices":20,"suggestions":21},"found",{"cik":6,"name":7,"ticker":8,"exchange":9,"listings":10,"delisted":15,"coverage":16},"0000874716","Idexx Laboratories Inc","IDXX","NASD",[11],{"ticker":8,"glr_ticker":12,"exchange":9,"type":13,"delisted_on":14},"NASD:IDXX","Common Stock",null,false,{"buybacks":17},{"published":18,"published_at":19},true,"2026-11-17",[],[],{"placement":23,"items":24},"company",[25,30,34,38,44],{"id":26,"title":27,"hint":28,"kind":29,"question":27,"target":14},"asr-3nc2","How does a 3nc2 ASR look for me?","Pricer · discount, size vs. ADV","analyze",{"id":31,"title":32,"hint":33,"kind":29,"question":32,"target":14},"compare-3nc2-6nc4","Compare 3nc2 vs 6nc4","Two pricers side by side",{"id":35,"title":36,"hint":37,"kind":29,"question":36,"target":14},"backtest-2y","Backtest an ASR over 2 years","Backtest · chart",{"id":39,"title":40,"hint":41,"kind":42,"question":14,"target":43},"outstanding","What do I have outstanding?","Public · no email needed","page","buybacks#outstanding",{"id":45,"title":46,"hint":47,"kind":48,"question":14,"target":14},"convert-terms","Terms for a new convert","Coming next","soon",{"view":50,"sort":51,"total":52,"generated_at":53,"items":54,"next_cursor":14},"all","newest",3,"2026-11-20T10:10:27.396916Z",[55,69,80],{"id":56,"type":57,"event_date":58,"company":59,"amount_usd":60,"amount_estimated":15,"shares":61,"headline":62,"source":63},"2c6804a1-6b24-5e2d-9180-ed7aa0a3fc62","quarterly_repurchase","2026-08-31",{"cik":6,"name":7,"ticker":8,"exchange":9},111818964,198600,"Idexx Laboratories Inc repurchased 198,600 shares ($112m) in the quarter to Aug 31, 2026",{"accession":64,"form":65,"as_of":66,"filed_at":67,"url":68},"0000874716-26-000135","10-Q","2026-09-30","2026-11-02","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F874716\u002F000087471626000135\u002F",{"id":70,"type":57,"event_date":71,"company":72,"amount_usd":73,"amount_estimated":15,"shares":74,"headline":75,"source":76},"3a2bde61-6959-506a-bc70-08ec19ceff79","2026-06-30",{"cik":6,"name":7,"ticker":8,"exchange":9},332343893.55,582329,"Idexx Laboratories Inc repurchased 582,329 shares ($332m) in the quarter to Jun 30, 2026",{"accession":77,"form":65,"as_of":71,"filed_at":78,"url":79},"0000874716-26-000123","2026-08-04","https:\u002F\u002Fwww.sec.gov\u002FArchives\u002Fedgar\u002Fdata\u002F874716\u002F000087471626000123\u002F",{"id":81,"type":82,"event_date":83,"company":84,"amount_usd":85,"amount_estimated":18,"shares":86,"headline":87,"source":88},"01d6efbd-723f-53f1-ae20-d64407a76c49","authorization_new","1999-08-13",{"cik":6,"name":7,"ticker":8,"exchange":9},53838720000,78000000,"Idexx Laboratories Inc authorizes repurchase of up to 78.0m shares",{"accession":64,"form":65,"as_of":66,"filed_at":67,"url":68}]